Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report.

Medicine (Baltimore)

Renal Division, Department of Medicine, Peking University First Hospital Peking University Institute of Nephrology Key Laboratory of Renal Disease, Ministry of Health of China Key Laboratory of Chronic Kidney Disease Prevention and Treatment (Peking University), Ministry of Education Department of Nephrology, The First Affiliated Hospital of Chinese PLA General Hospital, Beijing, China.

Published: June 2017

Rationale: C3 glomerulonephritis (C3GN) and complement-mediated hemolytic uremic syndrome (HUS) both result from the abnormal regulation of the complement system. A significant number of patients with C3GN or complement-mediated HUS have mutations of more than 1 complement protein. This discovery has had a major impact on identifying the underlying cause of familial C3GN or complement-mediated HUS.

Patient Concerns: We report the cases of 2 brothers (herein referred to as patient II-1 and patient II-9), both with complement disorders that differed in their clinical and genetic features.

Diagnoses: Patient II-1 clinically presented with nephrotic syndrome and acute kidney injury and pathologically presented with C3GN combined with thrombotic microangiopathy (TMA) and subacute tubulointerstitial nephritis. Meanwhile, patient II-9 clinically presented with HUS and pathologically presented with TMA combined with acute severe tubular injury.

Interventions: Screenings for genetic mutations contributed to complement system dysregulation were performed on patient II-1.

Outcomes: The genome sequencing identified that patient II-1 had a heterozygous mutation in the C3 gene (c.C1774T/p.R592W). Nine other relatives of the brothers were checked for this C3 mutation and only the daughter of patient II-1 (herein referred to as patient III-2) carried it, but so far, she does not have any clinical manifestations of kidney disease.

Lessions: Family members with a dysregulation of the complement alternative pathway may differ in its clinical and genetic features.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478328PMC
http://dx.doi.org/10.1097/MD.0000000000007144DOI Listing

Publication Analysis

Top Keywords

patient ii-1
16
c3gn complement-mediated
12
dysregulation complement
8
complement alternative
8
alternative pathway
8
complement system
8
patient
8
referred patient
8
patient ii-9
8
clinical genetic
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!